Page 4 - Les meilleurs doctors traitant la maladie suivante : Adénocarcinome - TOP -106 des médecins

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Spécialisé exclusivement en radiothérapie, le Dr Michael Van Kampen propose des approches de traitement ciblées à la Clinique Nordwest.

• Se concentrer sur les techniques de radiothérapie de précision
• Travailler avec une technologie de radiothérapie avancée
• Faire partie d'une équipe d'oncologie multidisciplinaire

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Le Dr Karen Drumea est une spécialiste en radiothérapie et oncologue au centre médical Rambam, se concentrant sur des plans de traitement précis et efficaces.

• Se spécialiser en radiothérapie pour l'adénocarcinome
• Travailler au centre médical Rambam, une institution de santé de premier plan
• Se consacrer aux soins personnalisés des patients

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Zalmanova est spécialisée en radiothérapie, avec un accent particulier sur l'adénocarcinome, au centre médical Assuta.

• Radiothérapeute experte en traitements par radiation ciblée
• Travailler au centre médical Assuta, reconnu pour ses soins oncologiques de pointe
• Élaborer des plans de traitement personnalisés pour les patients atteints d'adénocarcinome

Dirige l'ensemble du centre d'oncologie en tant que médecin chef au centre médical Assuta.

• Se spécialiser en oncologie médicale et en traitement du cancer
• Posséder une vaste expérience dans la gestion de cas de cancer complexes
• Superviser les soins aux patients et les protocoles d'un service d'oncologie de premier plan

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Kinas se spécialise dans les chirurgies oncologiques complexes, y compris les interventions du pancréas et des voies biliaires, aux hôpitaux Büyük Anadolu.

• Expert en chirurgie oncologique avec une spécialisation dans les cancers gastro-intestinaux
• Réaliser des chirurgies bariatriques et métaboliques avancées
• Qualifié pour les opérations du cancer du sein et de la thyroïde

Le Dr Derin est l'auteur de plus de 30 publications scientifiques sur le traitement des tumeurs malignes et est un nom reconnu parmi les oncologues turcs et européens.

• Spécialiste de premier plan en oncologie médicale au Liv Hospital Ulus
• Expert en cancers gastro-intestinaux, pulmonaires et gynécologiques tels que l'utérus et l'ovaire
• Auteur de plus de 30 articles de recherche nationaux et internationaux
• Membre actif de la Société européenne d'oncologie médicale (ESMO)
• Professeur agrégé doté d'une vaste expérience clinique et académique

Le Prof. Assoc. Murat Ayhan est spécialisé en oncologie moléculaire et en immunothérapie au Liv Hospital Vadistanbul, se concentrant sur les traitements avancés de l'adénocarcinome.

• Recherches approfondies dans les essais cliniques de phase II et III pour les cancers du sein et du poumon
• Publication de nombreuses études sur les résultats des traitements du cancer et les impacts du COVID-19
• Membre de la Société Européenne d'Oncologie Médicale (ESMO) et de la Société Turque d'Oncologie Médicale
• Rédaction de chapitres sur les thérapies ciblées dans des manuels d'oncologie médicale

Le Dr Lee Kwang Beom est un oncogynécologue spécialisé en chirurgie laparoscopique au Gachon University Gil Medical Center.

• Spécialiste des opérations laparoscopiques pour le traitement du cancer
• Se concentrer spécifiquement sur les cas d'oncologie gynécologique
• Appliquer des techniques de chirurgie mini-invasive

Le Dr Tarkan se spécialise dans les chirurgies complexes du cancer de l'estomac, alliant précision chirurgicale et dernières avancées en oncologie.

• Membre de l'Association Turque de Chirurgie Bariatrique
• Affilié à la Fédération Internationale pour la Chirurgie de l'Obésité et des Troubles Métaboliques
• Diplômé de la Faculté de Médecine de l'Université de Dicle

Spécialisé dans les techniques laser avancées pour les procédures urologiques, y compris les traitements de la prostate et de la vessie au Dievo Surgery Center.

• Réaliser l'énucléation et la vaporisation de la prostate au laser
• Être expert en techniques mini-invasives d'extraction de calculs rénaux
• Être qualifié en néphrectomie radicale laparoscopique et en chirurgie plastique pelvi-urétérale
• Pratiquer des reconstructions urétrales complexes et des réparations de la vessie